systemic ALCL patients

Related by string. * SYSTEMIC . Systemic : systemic lupus erythematosus SLE . systemic lupus erythematosus . systemic fungal infections . systemic lupus / ALCLS : Cellectis Alternext ALCLS . Cellectis SA Alternext ALCLS . cell lymphoma ALCL . refractory systemic ALCL / pa tients . PATIENTS . PATIENT . Patients : Breast Cancer Patients . terminally ill patients . Patient Safety * *

Related by context. Frequent words. (Click for all words.) 48 evaluable patients 47 relapsed 45 evaluable 45 cutaneous T cell 45 Non Hodgkin Lymphoma 45 hepatocellular carcinoma HCC 45 SPRYCEL 44 fludarabine 44 liver metastases 44 relapsing remitting multiple sclerosis 44 bipolar depression 44 Hodgkin Lymphoma 43 HGS ETR1 43 Pixantrone 43 HCV infection 43 myelofibrosis 43 IMGN# 43 adalimumab 43 vandetanib 43 Phase 2a trial 43 lupus nephritis 43 blinatumomab 43 relapsing remitting MS 43 peginterferon 43 TREANDA 42 myelodysplastic syndromes 42 HER2 positive 42 FOLOTYN 42 brain metastases 42 major depressive disorder 42 metastatic pancreatic cancer 42 Marqibo 42 chronic myeloid leukemia CML 42 Rituximab 41 myelodysplastic syndromes MDS 41 Phase Ib 41 dasatinib 41 HRPC 41 mg BID 41 abatacept 41 azathioprine 40 HER2 positive breast cancer 40 opioid dependence 40 sunitinib 40 VIDAZA 40 Ribavirin 40 chronic hepatitis C 40 metastatic colorectal cancer 40 sorafenib 40 advanced NSCLC 40 perifosine 40 hormone receptor positive 40 temozolomide 39 metastatic melanoma 39 dose escalation trial 39 Phase 2a clinical 39 AP# [003] 39 chronic lymphocytic leukemia 39 follicular lymphoma 39 NSCLC 39 renal cell carcinoma 39 quetiapine 39 PEGINTRON 39 Phase IIa trial 39 Non Hodgkin lymphoma 39 antiviral therapy 39 Genasense 39 aripiprazole 39 Phase 1b 38 monotherapy 38 citalopram 38 manic episodes 38 depressive episodes 38 Clolar 38 Xcytrin 38 eculizumab 38 metastatic prostate cancer 38 hormone refractory prostate cancer 38 glioblastoma 38 metastatic disease 38 Vidaza 38 natalizumab 38 brentuximab vedotin 38 chemotherapy regimen 38 panitumumab 38 pemetrexed 38 Phase 2b study 38 chronic lymphocytic leukemia CLL 38 ofatumumab 37 dose escalation 37 ZEVALIN 37 mCRC 37 resistant ovarian cancer 37 clozapine 37 randomized #:# 37 RG# [001] 37 Vectibix 37 plus ribavirin 37 refractory 37 anti TNF 37 Phase 2b clinical

Back to home page